Avita Medical
RCEL
#9203
Rank
HK$0.83 B
Marketcap
HK$27.40
Share price
-0.28%
Change (1 day)
-73.36%
Change (1 year)
Categories

Avita Medical (RCEL) - Cash on Hand

Cash on Hand as of September 2025 : HK$0.18 Billion

According to Avita Medical 's latest financial reports the company has HK$0.18 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avita Medical - Cash on Hand chart (from 2019 to 2019)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$0.27 B-59.95%
2023-12-31HK$0.69 B12.2%
2022-12-31HK$0.61 B
2021-06-30HK$0.85 B50.66%
2020-06-30HK$0.57 B415.65%
2019-06-30HK$0.11 B74.93%
2018-06-30HK$63.27 M262.44%
2017-06-30HK$17.45 M-17.3%
2016-06-30HK$21.11 M1763.76%
2015-06-30HK$1.13 M-95.49%
2014-06-30HK$25.1 M-63.41%
2013-06-30HK$68.6 M2.5%
2012-06-30HK$66.92 M-41.03%
2011-06-30HK$0.11 B397.9%
2010-06-30HK$22.79 M16.2%
2009-06-30HK$19.61 M-68.98%
2008-06-30HK$63.24 M-8.46%
2007-06-30HK$69.09 M88.93%
2006-06-30HK$36.57 M
2004-06-30HK$13.67 M
2002-12-31HK$9.71 M-38.84%
2001-12-31HK$15.88 M-19.86%
2000-12-31HK$19.82 M38.7%
1999-12-31HK$14.29 M9347.44%
1998-12-31HK$0.15 M-65.28%
1997-12-31HK$0.43 M1414.51%
1996-12-31HK$0.02 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novocure
NVCR
HK$8.04 B 4,333.15% Jersey
Novavax
NVAX
HK$5.93 B 3,172.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
HK$88.05 M-51.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
HK$0.97 B 437.95%๐Ÿ‡ฌ๐Ÿ‡ง UK